In today’s dynamic political landscape, European pharmaceutical companies have a unique opportunity to thrive despite the challenges presented by evolving US policies. While tariffs and cost pressures may cause hesitation, this moment calls for innovation and bold strategies. Are these obstacles a chance for growth, or merely an excuse to hold back?

Since late 2022, I am leading the Roche Pharma corporate Voice-of-the-customer (VoC, customer feedback) Program. During the past ~2 years, I have been designing, setting-up and deploying VoC @Roche Pharma. As part of that I have set-up a lean and high performing cross-functional matrix team driving the effort. The program’s set-up includes … Since the MVP had been activated in summer 2023, we see an increasing number of VoC success stories across the organization, showing real-life proof of business impact and value. CLIENT:Roche Pharma Global Product Strategy(as a Roche employee)PROJECT TIME FRAME: September 2022 –…